arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Precision BioSciences, Inc.

DTIL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$6.64
▼ -1.0% Today
as of Oct 23, 16:02 ET
Last 30 days -3.21% Sep 14 → Oct 23
$5.66 $6.07 $6.48 $6.89 $7.30 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$6.69
High
$6.92
Low
$6.58
Volume
$132,427
Avg Vol
$295,717
Mkt Cap
$173M
P/E (TTM)
—
Beta
—
52w High
$9.62
52w Low
$3.53
Div Yield
—
Shares Out
$26M

Recent Press Releases & News last 60 days · 1 item

DTIL earnings at a glance

Precision BioSciences, Inc. (DTIL) is scheduled to report earnings on Monday, November 2, 2026 — in 10 days. Analysts expect earnings per share of -$1.02, compared with -$1.84 in the same quarter last year (+45%). The options market is pricing a move of about ±78.9% after the report, a range of roughly $1.40 to $11.88 from today's $6.64. Over its last 6 reports the stock rose the next day 1 time and fell 5, moving ±6.3% on average; after the most recent report on Aug 6, 2026 it moved -0.7%. That means options currently expect more movement than DTIL has typically delivered. DTIL beat the consensus EPS estimate in 2 of its last 6 reported quarters. Implied volatility is currently 7%. The share price of $6.64 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$3.53
$9.62
51% of range
Avg surprise (last 6)
-487.4%
Avg reaction (last 6)
-2.3%
17% positive
Latest IV / EM
668%
EM ±78.9% · $8 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.75$-3.90$-1.04$1.81$4.67 Actual $-6.75Actual $-3.13Actual $-2.10Actual $1.70Actual $4.67Actual $-2.25Actual $-2.21Est $-0.43Actual $-2.13Est $-0.09Actual $-1.84Est $-0.31Actual $0.36Est $-0.21Actual $-0.34Est $-0.27Actual $-0.71Est $-0.74 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-33M$-22M$-11M$371,925$11M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Aug 6, 2026Jun/2026 $-0.71 $-0.74 +4.0% +65.3% -0.7% earnings
Tue May 5, 2026Mar/2026 $-0.34 $-0.27 -25.9% +84.6% -2.4% earnings
Thu Mar 12, 20268K 2026-03-12 $0.36 $-0.21 +271.4% — +12.1% earnings
Mon Nov 3, 2025Sep/2025 $-1.84 $-0.31 -493.6% — -9.8% earnings
Thu Aug 7, 2025Jun/2025 $-2.13 $-0.09 -2,267% — -5.0% earnings
Thu May 15, 2025Mar/2025 $-2.21 $-0.43 -413.9% — -8.1% earnings
Mon Sep 30, 2024Sep 2024 $-2.25 — — — — financials
Sun Jun 30, 2024Jun 2024 $4.67 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.70 — — — — financials
Sat Sep 30, 2023Sep 2023 $-2.10 — — — — financials
Fri Jun 30, 2023Jun 2023 $-3.13 — — — — financials
Fri Mar 31, 2023Mar 2023 $-6.75 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Nov 2, 2026Sep/2026OTHER -$1.02-$1.84 +44.6%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$0$11M—$13,000$18,000$29,000—$576,000
Cost of revenue————————
Gross profit————————
Operating income$-19M$-9M—$-21M$-22M$-22M—$-21M
Net income$-33M$-18M—$-22M$-24M$-21M—$-16M
EPS (diluted)$-1.26$-0.75—$-1.84$-2.13$-2.21—$-2.25

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$86M$99M$111M$45M$62M$77M$86M$99M
Inventory————————
Total current assets$92M$109M$119M$52M$70M$82M$95M$111M
Total assets$126M$144M$154M$94M$109M$124M$136M$153M
Long-term debt————————
Total liabilities$81M$68M$62M$77M$75M$75M$80M$88M
Total equity$45M$76M$92M$17M$34M$49M$56M$65M

Implied volatility — last 90 days

36%299%561%823%1085% Jun 24 — IV 52% · EM ±10.4%Jun 25 — IV 214% · EM ±41.9%Jun 26 — IV 148% · EM ±28.3%Jun 30 — IV 199% · EM ±34.4%Jul 01 — IV 144% · EM ±24.1%Jul 13 — IV 697% · EM ±58.2%Jul 14 — IV 822% · EM ±59.4%Jul 20 — IV 126% · EM ±29.7%Jul 21 — IV 103% · EM ±23.9%Jul 22 — IV 85% · EM ±19.5%Jul 23 — IV 136% · EM ±30.7%Jul 28 — IV 78% · EM ±16.0%Jul 30 — IV 135% · EM ±26.4%Jul 31 — IV 381% · EM ±73.0%Aug 03 — IV 60% · EM ±10.6%Aug 05 — IV 72% · EM ±12.0%Aug 07 — IV 64% · EM ±10.0%Aug 19 — IV 1086% · EM ±64.1%Aug 24 — IV 165% · EM ±34.5%Aug 25 — IV 164% · EM ±33.6%Aug 26 — IV 169% · EM ±33.9%Aug 27 — IV 334% · EM ±65.5%Aug 28 — IV 37% · EM ±7.1%Aug 31 — IV 207% · EM ±36.6%Sep 10 — IV 585% · EM ±69.1%Sep 11 — IV 625% · EM ±69.0%Sep 22 — IV 360% · EM ±73.7%Sep 24 — IV 403% · EM ±79.0%Sep 25 — IV 466% · EM ±89.2%Sep 30 — IV 179% · EM ±30.0%Oct 01 — IV 498% · EM ±80.6%Oct 02 — IV 505% · EM ±78.8%Oct 06 — IV 611% · EM ±80.6%Oct 08 — IV 668% · EM ±78.9%

Sector peers

DTIL earnings FAQ

When is DTIL's next earnings date?

Precision BioSciences, Inc. is expected to report on November 2, 2026.

What is DTIL's expected move for earnings?

Options currently price a move of about ±78.9%, or $5.24 per share either way from $6.64.

How does DTIL stock usually react to earnings?

Across the last 6 reports the average next-day move was ±6.3%, up 1 times and down 5 times.

What EPS are analysts expecting from Precision BioSciences, Inc.?

The consensus estimate is -$1.02 per share, versus -$1.84 a year ago.

What is DTIL's implied volatility?

DTIL's at-the-money implied volatility is about 7% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.